NDC properties for NDC 9 0597-0570
NDC item 00597057032
NDC 9 | 0597-0570 |
---|---|
NDC 10 | 0597-0570-32 |
NDC Item | 00597057032 |
packaging | 0.4 mL in 1 SYRINGE |
packaging | 1 in 1 TRAY |
FDA SPL set id | 784593 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG LABEL |
NDC item 00597057550
NDC 9 | 0597-0575 |
---|---|
NDC 10 | 0597-0575-50 |
NDC Item | 00597057550 |
packaging | 2 KIT in 1 CARTON (0597-0575-50) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0570-32) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784593 |
Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-04-30 |
Marketing status | ACTIVE |
NDC item 82009014422
NDC 9 | 82009-144 |
---|---|
NDC 10 | 82009-144-22 |
NDC Item | 82009014422 |
packaging | 2 KIT in 1 CARTON (82009-144-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-145-11) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
BLA | BLA761058 |
FDA SPL set id | 784783 |
Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-04-30 |
Marketing status | ACTIVE |
NDC item 82009014511
NDC 9 | 82009-145 |
---|---|
NDC 10 | 82009-145-11 |
NDC Item | 82009014511 |
packaging | 0.4 mL in 1 SYRINGE |
packaging | 1 in 1 TRAY |
FDA SPL set id | 784783 |
Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
Label type | HUMAN PRESCRIPTION DRUG LABEL |